← Evidence map

ArticleVaccines2026

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season.

Mikhail P Kostinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season. | OpenQuestion